ArticleBMC cancer2025
Establishment and characterization of CHC-X1: the third human combined hepatocellular-cholangiocarcinoma cell line.
Huan Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it